[Guidant] is in a situation where they have to be extremely forthcoming and precise in their communications. So I'm inclined to take them at their word. |
I think if the two sides were close to a deal you wouldn't see a lawsuit. |
I think it's very wise for him to stay on as a consultant. Dane is the face and soul of that company. |
I think right now it's on the crazy end of the spectrum. |
I think they are for sale. |
I think today's bid was a 'don't-come-near-me' bid. |
I was told I have internal bleeding in my brain. My ankle is swollen and so is the back of my knee. The person hit my left side as I walked on the shoulder of the road. |
J&J made a bid that was the minimum bid to be considered in the game. Now Boston is testing whether they need to go higher. I think they will if they need to, but if $68 is J&J's price, why pay more now? |
The deal's not a deal until the FTC rules, ... [Wednesday] was the first punch. |
There is nothing to complain about. |
They want a lower price and they're threatening not to go through with the deal if they don't get it. |
They're being careful not to lower the investment rating for their credit. Paying this price doesn't jeopardize the company in any way. |
They're in a headlock over price, |
This eliminates J&J's negotiating position that immediacy is an important element of their deal. They've eliminated the time-value-of-money risk. |
What they're doing is moving forward with the J&J process, which is at this point more official than the Boston Scientific process. Boston Scientific has not yet made an official offer for the company. They've merely proposed an offer. |